Status report
Get it in writing
The official USPTO status record for CLAIMEL, serial 77205809, as a dated PDF. One price, one document, delivered in about a minute.
INSTANT DELIVERY
Trademark Status Report
$7.99
The USPTO's own status record for this mark, on one dated page.
- Current status with a plain-English verdict
- Owner, classes, filing basis, and every key date
- The mark as it appears on the federal record
- Every prosecution event, filing to today
- Source-cited with the exact retrieval date
Built from the USPTO's TSDR record. Assignment chain of title and TTAB proceeding files sit in separate USPTO systems and are not included.
Preview
◆ TRADEMARKCHECKER.AITRADEMARK STATUS REPORT
CLAIMELSerial 77205809 · Principal Register
Dead · Refused
Owner: Glaxo Group Limited
Class 005 - Pharmaceuticals
Filed Jun 14, 2007
The record shows that CLAIMEL, filed by Glaxo Group Limited, is no longer active – it was abandoned on March 7 2011 because no Statement of Use was filed after the Notice of Allowance was issued. The only goods listed are “pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of … and for vaccines” in International Class 005, so a similar name used for medicines or vaccines would be the closest area of concern. The record does not give Glaxo control over every possible use of the word CLAIMEL in other industries. Because the application was on the Principal Register and never moved to the Supplemental Register, there is no supplemental‑register sequence to note. The latest meaningful event is the abandonment notice mailed on March 7 2011, and the history shows no oppositions, cancellations or court actions. I'd treat this as a moderate concern if you plan a pharmaceutical‑related brand with a similar name.
Full event history, owner details, and verdict inside.
The way I'd use it, honestly, is as the thing you attach when a bank, a marketplace, or a co-founder asks "are we clear on the name". It answers in one page.